×
About 21,463 results

ALLMedicine™ Pulmonary Fibrosis Center

Research & Reviews  10,323 results

Quantification of pulmonary perfusion in idiopathic pulmonary fibrosis with first pass ...
https://doi.org/10.1136/thoraxjnl-2019-214375
Thorax Weatherley ND, Eaden JA et. al.

Dec 4th, 2020 - Idiopathic pulmonary fibrosis (IPF) is a fatal disease of lung scarring. Many patients later develop raised pulmonary vascular pressures, sometimes disproportionate to the interstitial disease. Previous therapeutic approaches that have targeted pu...

Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis...
https://doi.org/10.1136/thoraxjnl-2020-214770
Thorax Valenzi E, Yang H et. al.

Dec 3rd, 2020 - Lung microbiota profiles in patients with early idiopathic pulmonary fibrosis (IPF) have been associated with disease progression; however, the topographic heterogeneity of lung microbiota and their roles in advanced IPF are unknown. We performed ...

Longitudinal Changes in Clinical Features, Management, and Outcomes of Idiopathic Pulmo...
https://doi.org/10.1513/AnnalsATS.202005-451OC
Annals of the American Thoracic Society; Moon SW, Kim SY et. al.

Dec 3rd, 2020 - In recent decades, diagnosis and treatment recommendations for idiopathic pulmonary fibrosis (IPF) have changed. In Korea, the average life expectancy has increased, unmet healthcare needs have been reduced, and the number of computed tomography (...

Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Tw...
https://doi.org/10.1159/000509556
Respiration; International Review of Thoracic Diseases; Faverio P, Piluso M et. al.

Dec 2nd, 2020 - The prevalence and natural history of progressive fibrosing interstitial lung diseases (PF-ILDs), and their response to commonly used treatments in real life are largely unknown. The aim of the study was to describe the prevalence, clinical charac...

In silico immune infiltration profiling combined with functional enrichment analysis re...
https://doi.org/10.1371/journal.pone.0242900
PloS One; Wu YY, Wang SH et. al.

Dec 2nd, 2020 - COVID-19, caused by SARS-CoV-2, has rapidly spread to more than 160 countries worldwide since 2020. Despite tremendous efforts and resources spent worldwide trying to explore antiviral drugs, there is still no effective clinical treatment for COVI...

see more →

Guidelines  25 results

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice G...
https://www.atsjournals.org/doi/10.1164/rccm.201807-1255ST
Raghu, G.

Aug 31st, 2018 - This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and.

Evaluation of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society ...
https://cts-sct.ca/wp-content/uploads/2018/02/Evaluation-of-pts-w_ILD-paper.pdf
Kerri A. Johannson

Aug 21st, 2017 - Fibrotic ILD represents a large heterogeneous group of disorders that are challenging to diagnose. The evaluation of patients with fibrotic ILD should include a thorough history, physical examination, basic serological testing, pulmonary function.

Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fib...
http://www.thoracic.org/statements/resources/interstitial-lung-disease/animal-models-pulm-fibrosis.pdf
R. Gisli Jenkins

Apr 30th, 2017 - Numerous compounds have shown efficacy in limiting development of pulmonary fibrosis using animal models, yet few of these compounds have replicated these beneficial effects in clinical trials. Given the challenges associated with performing clini.

Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment.
https://doi.org/10.1159/000464332
Respiration; International Review of Thoracic Diseases; Funke-Chambour M, Azzola A et. al.

Mar 27th, 2017 - Idiopathic pulmonary fibrosis (IPF) is a severe progressive and irreversible lung disease. Novel antifibrotic drugs that slow disease progression are now available. However, many issues regarding patient management remain unanswered, such as the c...

The Intersection of GERD, Aspiration, and Lung Transplantation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948126
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A; Patti MG, Vela MF et. al.

May 24th, 2016 - Lung transplantation is a radical but life-saving treatment option for patients with end-stage lung diseases, such as idiopathic pulmonary fibrosis (IPF) and scleroderma. In light of the proposed association and controversy linking gastroesophagea...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  10,663 results

Quantification of pulmonary perfusion in idiopathic pulmonary fibrosis with first pass ...
https://doi.org/10.1136/thoraxjnl-2019-214375
Thorax Weatherley ND, Eaden JA et. al.

Dec 4th, 2020 - Idiopathic pulmonary fibrosis (IPF) is a fatal disease of lung scarring. Many patients later develop raised pulmonary vascular pressures, sometimes disproportionate to the interstitial disease. Previous therapeutic approaches that have targeted pu...

Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis...
https://doi.org/10.1136/thoraxjnl-2020-214770
Thorax Valenzi E, Yang H et. al.

Dec 3rd, 2020 - Lung microbiota profiles in patients with early idiopathic pulmonary fibrosis (IPF) have been associated with disease progression; however, the topographic heterogeneity of lung microbiota and their roles in advanced IPF are unknown. We performed ...

Longitudinal Changes in Clinical Features, Management, and Outcomes of Idiopathic Pulmo...
https://doi.org/10.1513/AnnalsATS.202005-451OC
Annals of the American Thoracic Society; Moon SW, Kim SY et. al.

Dec 3rd, 2020 - In recent decades, diagnosis and treatment recommendations for idiopathic pulmonary fibrosis (IPF) have changed. In Korea, the average life expectancy has increased, unmet healthcare needs have been reduced, and the number of computed tomography (...

Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Tw...
https://doi.org/10.1159/000509556
Respiration; International Review of Thoracic Diseases; Faverio P, Piluso M et. al.

Dec 2nd, 2020 - The prevalence and natural history of progressive fibrosing interstitial lung diseases (PF-ILDs), and their response to commonly used treatments in real life are largely unknown. The aim of the study was to describe the prevalence, clinical charac...

In silico immune infiltration profiling combined with functional enrichment analysis re...
https://doi.org/10.1371/journal.pone.0242900
PloS One; Wu YY, Wang SH et. al.

Dec 2nd, 2020 - COVID-19, caused by SARS-CoV-2, has rapidly spread to more than 160 countries worldwide since 2020. Despite tremendous efforts and resources spent worldwide trying to explore antiviral drugs, there is still no effective clinical treatment for COVI...

see more →

News  425 results

PPI Use Not Associated With Improved Survival in Idiopathic Pulmonary Fibrosis
https://www.staging.medscape.com/viewarticle/936990

Sep 7th, 2020 - Takeaway In patients with idiopathic pulmonary fibrosis (IPF), the use of proton pump inhibitors (PPIs) is not associated with improved survival and reduced incidence of respiratory-related hospitalisation compared with non-use. Why this matters F...

PPI Use Not Associated With Improved Survival in Idiopathic Pulmonary Fibrosis
https://www.medscape.com/viewarticle/936990

Sep 7th, 2020 - Takeaway In patients with idiopathic pulmonary fibrosis (IPF), the use of proton pump inhibitors (PPIs) is not associated with improved survival and reduced incidence of respiratory-related hospitalisation compared with non-use. Why this matters F...

Fast Five Quiz: Idiopathic Pulmonary Fibrosis Comorbidities and Complications
https://reference.medscape.com/viewarticle/925460_5

Jul 12th, 2020 - An increased prevalence of both OSA and GERD has been noted in patients with IPF. However, OSA has not been found to be a risk factor for GERD among patients with IPF. The use of GERD medications has been associated with longer survival times and ...

Fast Five Quiz: Idiopathic Pulmonary Fibrosis Comorbidities and Complications
https://reference.medscape.com/viewarticle/925460_6

Jul 12th, 2020 - Approximately 30% of patients with IPF have comorbid emphysema. The presence of comorbid emphysema does not disqualify patients with IPF for consideration or evaluation for lung transplantation. Comorbid emphysema is more commonly seen in men with...

Fast Five Quiz: Idiopathic Pulmonary Fibrosis Comorbidities and Complications
https://reference.staging.medscape.com/viewarticle/925460

Jul 12th, 2020 - Idiopathic pulmonary fibrosis (IPF) is a chronic disease of unknown etiology that is generally associated with a poor prognosis. Although it is characterized by the involvement of a single organ, numerous comorbidities and complications can arise ...

see more →

Patient Education  23 results see all →